Series B - Atropos Health

Series B - Atropos Health

Investment Firm

Overview

Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.

Announced Date

May 23, 2024

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Valtruis

Valtruis

Valtruis is a early_stage_venture firm.

Participant Investors

9

Investor Name
Participant InvestorSanofi Ventures
Participant InvestorValtruis
Participant InvestorPresidio Ventures
Participant InvestorEmerson Collective
Participant InvestorTouchdown Ventures

Round Details and Background

Atropos Health raised $33000000 on 2024-05-23 in Series B

Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 28, 2020
Seed Round - Atropos Health
1-undefined
Aug 04, 2022
Series A - Atropos Health
4-14.0M
Sep 21, 2023
Venture Round - Atropos Health
5-undefined
May 23, 2024
Series B - Atropos Health
9-33.0M

Recent Activity

There is no recent news or activity for this profile.